January 25, 2013 Bend, OR – Clear Catheter Systems announces the launch of PROACT ™ (Prevent Retained-blood Outcomes with Active Clearance Technology), a continuous quality improvement (CQI) initiative for hospitals that aims to reduce costly complications and readmissions after heart surgery. PROACT targets complications caused by fluid retained in the chest (effusions) after heart surgery, which is a leading cause of readmissions nationally.
PleuraFlow® has been recognized with a 2011 GOOD DESIGN™ award in the Medical category. Founded in 1950, The GOOD DESIGN™ award is one of the world’s most prestigious international awards program for new industrial design. PleuraFlow® was selected from over 500 product designs from over 38 nations. This award comes to the company via its collaboration with Carbon Design, which helped design the PleuraFlow® Active Tube Clearance® System.
BEND, Ore., — Clear Catheter Systems, Inc., a leading developer of medical devices used in post surgical recovery announced that it has closed its first institutional round of financing. The $4 million round was co-led by Aphelion Capital and California Technology Ventures. Also participating in the financing was Research Corporation Technologies. Ned Scheetz, of Aphelion Capital and Alex Suh, of California Technology Ventures will join the board of…
PleuraFlow® was recognized with a bronze award in the 2011 Spark Awards. Encompassing a spectrum of categories including architecture, graphic design, branding, and product design, the Spark Awards recognize design’s ability to act as a catalyst, address problems, and improve lives.